Utah

Overview

Utah legalized medical cannabis in November 2018 via Proposition 2 (52.75%). The legislature subsequently passed HB 3001 in December 2018 (a substantially modified compromise framework) which became the operational basis for the program. Recreational cannabis remains illegal.

The program uses a pharmacy-medical-provider model distinct from the cultivator-dispensary vertical model in most other states: licensed pharmacists at state-regulated pharmacies dispense cannabis products to patients registered through the state's Electronic Verification System (EVS).

Medical program

Codified at Utah Code Title 26B Chapter 4 (Medical Cannabis Act), administered by the Utah Department of Health and Human Services Center for Medical Cannabis and the Utah Department of Agriculture and Food.

Qualifying conditions

The enumerated list includes:

• Cancer
• Epilepsy and seizure disorders
• Multiple sclerosis
• HIV/AIDS
• Crohn's disease and ulcerative colitis
• Alzheimer's disease
• Glaucoma
• Post-traumatic stress disorder
• Persistent nausea, cachexia
• Chronic pain (severe or intractable, with restricted opioid-alternative criteria)
• Hospice / terminal illness
• Autism (specific clinical thresholds)

Patient access

• Possession: 30-day supply. Typically up to 113 g of unprocessed cannabis flower or 20 g of THC in concentrate / edible-equivalent format.
• Approved forms: capsules, tablets, gummies, gelatinous cube blocks, sublingual products, transdermal patches, tinctures, vape cartridges, raw flower.
• Smoking is prohibited. Vaporization is permitted.
• Home cultivation: prohibited.
• Reciprocity: Utah does not recognize out-of-state medical cards.

Recreational status

Recreational cannabis is illegal under Utah Code Title 58 Chapter 37. Possession of any amount is at minimum a misdemeanor.

Patients and caregivers

• Patient minimum age: 21 (lower with compassionate-use exception via Compassionate Use Board approval: typically pediatric patients with terminal or treatment-resistant conditions).
• Caregiver minimum age: 18 (verify against current Utah DHHS rules).
• Caregivers per patient: up to 2 designated caregivers per patient (verify).
• Caregiver registration: via the Utah Center for Medical Cannabis; criminal background check.

Patient registration steps

1. Locate a Utah Qualified Medical Provider (QMP) registered with the state EVS. The Utah Center for Medical Cannabis maintains a provider directory. Limited-quantity Limited Medical Provider (LMP) status allows certain providers to certify up to 15 patients without full QMP licensure.
2. The QMP confirms a qualifying condition through an in-person evaluation and enters the recommendation into the EVS. Telehealth follow-up visits are permitted; the initial visit must be in person.
3. The patient applies through the Utah Center for Medical Cannabis online portal, submits identity documents and a photo, and pays the registration fee. Reduced fees apply for veterans and patients receiving certain disability benefits.
4. Once approved, the patient receives a state-issued medical-cannabis card valid for the recommendation period. Cards typically renew annually with a follow-up QMP visit.

Patients under 21 require Compassionate Use Board review and approval. Pediatric patients with terminal illness, autism, or treatment-resistant epilepsy are the primary populations served by this pathway.

Pharmacy-medical-provider model

Utah's program is structurally distinct from the cultivator-dispensary vertical model used in most other states. The Utah Department of Agriculture and Food licenses cultivators and processors; the Utah Department of Health and Human Services licenses pharmacies. The pharmacies are staffed by pharmacists licensed by the Utah Division of Professional Licensing under a Pharmacy Medical Provider (PMP) role.

Practical implications:

• Patients work with pharmacists for product selection rather than budtenders.
• Pharmacy locations are limited (currently fewer than 20 statewide) and concentrated along the Wasatch Front (Salt Lake City, Provo, Ogden).
• The PMP framework allows for some clinical guidance on dosing, drug interactions, and product selection that is uncommon in standard dispensary settings.

Reciprocity and visiting patients

Utah does not extend reciprocity to any out-of-state medical-cannabis program. Visiting patients carrying medical cards from Colorado, Nevada, Arizona, New Mexico, or any other state may not purchase from Utah pharmacies and remain subject to state criminal penalties for possession. Cannabis brought into Utah from another jurisdiction is contraband regardless of medical authorization in the source state.

Employment and workplace

Utah provides limited statutory protection for registered medical-cannabis patients. Public-sector employers may not discipline registered patients solely on the basis of registry status or off-duty medical use, with exceptions:

• Safety-sensitive positions: public and private employers may continue to enforce drug-free workplace policies for safety-sensitive roles.
• Federal contractor and DOT-regulated positions: federal drug-free workplace and DOT testing rules supersede state-level patient protection.
• Private employers: retain broad discretion to discipline or terminate employees for positive THC tests.

Workers' compensation rules continue to apply. A positive post-incident THC test may result in benefit denial unless the patient can document medical use within certified parameters at the time of the incident.

Hemp-derived intoxicants

Utah regulates hemp-derived intoxicating cannabinoids more tightly than most states. Delta-8 THC, delta-10 THC, THC-O, HHC, and similar compounds are treated as controlled substances under Utah law when they exceed the federal Farm Bill 0.3% THC threshold (calculated on a total-THC basis including delta-8 isomers). Enforcement is by the Utah Department of Agriculture and Food and the Utah Bureau of Investigation.

Recent legislative history

The Utah Legislature has revisited the Medical Cannabis Act in nearly every session since 2019. Notable amendments:

• 2020-2022: progressive adjustments to QMP eligibility, condition list, and product-form rules.
• 2023: SB 230 expanded the LMP framework and clarified pharmacist role.
• 2024: HB 230 adjusted possession-cap calculations and the EVS dosing-guidance framework.
• 2025-2026: ongoing legislative work on chronic-pain criteria, telehealth visits, and pharmacy licensure expansion. No comprehensive expansion to recreational use has advanced.

The April 2026 federal Schedule III rescheduling order produced no immediate Utah legislative response.

Federal context

Federal jurisdiction layers additional exposure on federal land, federal courthouses, military installations (Hill Air Force Base, Dugway Proving Ground), and interstate highways. The Mighty 5 national parks (Arches, Bryce Canyon, Canyonlands, Capitol Reef, Zion) and BLM-administered lands cover a substantial fraction of Utah land area where federal cannabis prohibition applies regardless of state medical authorization. I-15, I-70, I-80, and I-84 corridors see active state-patrol and federal interdiction activity.